Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Milligan R, Daher A, Graves PM.

Cochrane Database Syst Rev. 2019 Jul 5;7:CD012656. doi: 10.1002/14651858.CD012656.pub2. Review.

2.

Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999-2016.

Carlingford CN, Melrose W, Mokoia G, Graves PM, Ichimori K, Capuano C, Kim SH, Aratchige P, Nosa M.

Trop Med Health. 2019 Mar 15;47:20. doi: 10.1186/s41182-019-0141-1. eCollection 2019.

3.

GEOFIL: A spatially-explicit agent-based modelling framework for predicting the long-term transmission dynamics of lymphatic filariasis in American Samoa.

Xu Z, Graves PM, Lau CL, Clements A, Geard N, Glass K.

Epidemics. 2019 Jun;27:19-27. doi: 10.1016/j.epidem.2018.12.003. Epub 2018 Dec 29.

4.

Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys.

Berg Soto A, Xu Z, Wood P, Sanuku N, Robinson LJ, King CL, Tisch D, Susapu M, Graves PM.

Trop Med Health. 2018 Dec 4;46:41. doi: 10.1186/s41182-018-0123-8. eCollection 2018.

5.

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.

Dickson BFR, Graves PM, Aye NN, Nwe TW, Wai T, Win SS, Shwe M, Douglass J, Bradbury RS, McBride WJ.

PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006944. doi: 10.1371/journal.pntd.0006944. eCollection 2018 Nov.

6.

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.

Sheel M, Sheridan S, Gass K, Won K, Fuimaono S, Kirk M, Gonzales A, Hedtke SM, Graves PM, Lau CL.

PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006583. doi: 10.1371/journal.pntd.0006583. eCollection 2018 Jul.

7.

The extensive networks of frequent population mobility in the Samoan Islands and their implications for infectious disease transmission.

Xu Z, Lau CL, Zhou X, Fuimaono S, Soares Magalhães RJ, Graves PM.

Sci Rep. 2018 Jun 28;8(1):10136. doi: 10.1038/s41598-018-28081-x.

8.

Expanding the Vector Control Toolbox for Malaria Elimination: A Systematic Review of the Evidence.

Williams YA, Tusting LS, Hocini S, Graves PM, Killeen GF, Kleinschmidt I, Okumu FO, Feachem RGA, Tatarsky A, Gosling RD.

Adv Parasitol. 2018;99:345-379. doi: 10.1016/bs.apar.2018.01.003. Epub 2018 Feb 27.

PMID:
29530309
9.

Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.

Graves PM, Choi L, Gelband H, Garner P.

Cochrane Database Syst Rev. 2018 Feb 2;2:CD008152. doi: 10.1002/14651858.CD008152.pub5. Review.

10.

Overview of PacELF-the Pacific Programme for the Elimination of Lymphatic Filariasis.

Ichimori K, Graves PM.

Trop Med Health. 2017 Nov 1;45:34. doi: 10.1186/s41182-017-0075-4. eCollection 2017. No abstract available.

11.

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.

Lau CL, Sheridan S, Ryan S, Roineau M, Andreosso A, Fuimaono S, Tufa J, Graves PM.

PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005914. doi: 10.1371/journal.pntd.0005914. eCollection 2017 Sep.

12.

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.

Uthman OA, Graves PM, Saunders R, Gelband H, Richardson M, Garner P.

Malar J. 2017 Aug 22;16(1):346. doi: 10.1186/s12936-017-1989-3. Review.

13.

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration.

Coutts SP, King JD, Pa'au M, Fuimaono S, Roth J, King MR, Lammie PJ, Lau CL, Graves PM.

Trop Med Health. 2017 Aug 4;45:22. doi: 10.1186/s41182-017-0063-8. eCollection 2017.

14.

Lymphatic Filariasis in Mainland Southeast Asia: A Systematic Review and Meta-Analysis of Prevalence and Disease Burden.

Dickson BFR, Graves PM, McBride WJ.

Trop Med Infect Dis. 2017 Jul 27;2(3). pii: E32. doi: 10.3390/tropicalmed2030032. Review.

15.

Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu.

Taleo F, Taleo G, Graves PM, Wood P, Kim SH, Ozaki M, Joseph H, Chu B, Pavluck A, Yajima A, Melrose W, Ichimori K, Capuano C.

Trop Med Health. 2017 Jun 16;45:18. doi: 10.1186/s41182-017-0057-6. eCollection 2017.

16.

Identification and control of an isolated, but intense focus of lymphatic filariasis on Satawal Island, Federated States of Micronesia, in 2003.

Pretrick M, Melrose W, Chaine JP, Canyon D, Carron J, Graves PM, Bradbury RS.

Trop Med Health. 2017 Jun 9;45:17. doi: 10.1186/s41182-017-0050-0. eCollection 2017.

17.

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.

Allen T, Taleo F, Graves PM, Wood P, Taleo G, Baker MC, Bradley M, Ichimori K.

Trop Med Health. 2017 Jun 1;45:8. doi: 10.1186/s41182-017-0047-8. eCollection 2017.

18.

Relative Performance and Predictive Values of Plasma and Dried Blood Spots with Filter Paper Sampling Techniques and Dilutions of the Lymphatic Filariasis Og4C3 Antigen ELISA for Samples from Myanmar.

Masson J, Douglass J, Roineau M, Aye KS, Htwe KM, Warner J, Graves PM.

Trop Med Infect Dis. 2017 Apr 11;2(2). pii: E7. doi: 10.3390/tropicalmed2020007.

19.

Concordance between Plasma and Filter Paper Sampling Techniques for the Lymphatic Filariasis Bm14 Antibody ELISA.

Masson J, Douglass J, Roineau M, Aye KS, Htwe KM, Warner J, Graves PM.

Trop Med Infect Dis. 2017 Apr 7;2(2). pii: E6. doi: 10.3390/tropicalmed2020006.

20.

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.

Lau CL, Won KY, Lammie PJ, Graves PM.

PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005108. doi: 10.1371/journal.pntd.0005108. eCollection 2016 Nov.

Supplemental Content

Loading ...
Support Center